Neoadjuvant and Adjuvant Sintilimab Combined with Chemoradiotherapy Versus Chemoradiotherapy Alone in Stage TanyN3M0 Nasopharyngeal Carcinoma
Clinical trial NCT06680115 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06680115
- Sponsor
- First Affiliated Hospital of Guangxi Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2026-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.